← Scroll for more →
Zevra Therapeutics, Inc. (ZVRA)
Pharmaceutical Preparations
Latest Price
$10.36
TTM P/E
11.26
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
3.68
P/B Ratio
2.81
Valuation metrics
adjust assumptions →EPS: $1.35
Book value / share: $2.72
Formula: √(22.5 × EPS × BVPS)
Graham Number
$9.09
10% downside
EPS: $1.35
Target P/E: 11×
Formula: EPS × P/E
P/E Fair Value
$14.85
+48% upside
Institutional Ownership
79.3% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 5.11M | $73.0M | 8.61% | +652.4K | 2026-06-30 |
| FMR LLC | 4.92M | $70.0M | 8.28% | +1.70M | 2026-06-30 |
| Woodline Partners LP | 4.79M | $68.0M | 8.06% | +1.33M | 2026-06-30 |
| Vanguard Capital Management LLC | 2.64M | $37.0M | 4.45% | +169.6K | 2026-06-30 |
| Caption Management, LLC | 2.22M | $31.0M | 3.75% | -130.3K | 2026-06-30 |
| Nantahala Capital Management, LLC | 1.80M | $25.0M | 3.03% | -724.5K | 2026-06-30 |
| State Street Corp | 1.68M | $24.0M | 2.83% | +120.4K | 2026-06-30 |
| Geode Capital Management, LLC | 1.54M | $22.0M | 2.60% | +169.1K | 2026-06-30 |
| D. E. Shaw & Co., Inc. | 1.31M | $18.0M | 2.20% | +460.5K | 2026-06-30 |
| Qube Research & Technologies Ltd | 1.24M | $17.0M | 2.09% | +399.0K | 2026-06-30 |